Conjunctival Autologous Transplantation Using Fibrin Glue in Primary Pterygia
This study has been completed.
Sponsor:
Hospital de Olhos Sadalla Amin Ghanem
Information provided by:
Hospital de Olhos Sadalla Amin Ghanem
ClinicalTrials.gov Identifier:
NCT00949728
First received: July 17, 2009
Last updated: July 29, 2009
Last verified: July 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To evaluate the recurrence and postoperative complications rates after conjunctival autograft surgery using fibrin adhesive for primary pterygium
| Condition | Intervention |
|---|---|
|
Pterygium Primary |
Procedure: Conjunctival autograft using fibrin glue |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Conjunctival Autologous Transplantation Using Fibrin Glue in Primary Pterygia |
Further study details as provided by Hospital de Olhos Sadalla Amin Ghanem:
Primary Outcome Measures:
- Recurrence of pterygium after its excision with the conjunctival autograft technique. [ Time Frame: One, three and five months after surgery. ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Postoperative complications following the pterygium excision, such as partial graft detachment, dellen, granuloma or sutures failure. [ Time Frame: One day, one week and one month after surgery. ] [ Designated as safety issue: No ]
| Enrollment: | 151 |
| Study Start Date: | October 2006 |
| Study Completion Date: | July 2009 |
| Primary Completion Date: | August 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Fibrin glue |
Procedure: Conjunctival autograft using fibrin glue
Conjunctival autograft using fibrin glue in pterygium surgery
Other Name: Pterygium surgery using fibrin glue
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Clinical diagnosis of primary pterygium
- Symptomatic pterygium
- Limbal invasion
Exclusion Criteria:
- Secondary pterygium
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00949728
Locations
| Brazil | |
| Sadalla Amin Ghanem Eye Hospital | |
| Joinville, SC, Brazil, 89201-010 | |
Sponsors and Collaborators
Hospital de Olhos Sadalla Amin Ghanem
Investigators
| Principal Investigator: | Renan F Oliveira | |
| Study Director: | Ramon C Ghanem, M.D. | Sadalla Amin Ghanem Eye Hospital |
More Information
Publications:
| Responsible Party: | Ramon Coral Ghanem, Sadalla Amin Ghanem Eye Hospital |
| ClinicalTrials.gov Identifier: | NCT00949728 History of Changes |
| Other Study ID Numbers: | cola106 |
| Study First Received: | July 17, 2009 |
| Last Updated: | July 29, 2009 |
| Health Authority: | Brazil: National Committee of Ethics in Research |
Keywords provided by Hospital de Olhos Sadalla Amin Ghanem:
|
Pterygium Autologous Transplantation Conjunctiva Fibrin Tissue Adhesive Recurrence |
Additional relevant MeSH terms:
|
Pterygium Conjunctival Diseases Eye Diseases Fibrin Tissue Adhesive Hemostatics |
Coagulants Hematologic Agents Therapeutic Uses Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 23, 2013